ArticleFrontiers in nutrition2023

Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism.

Fei-Fei Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.